Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Karakasi, M-V., Vasilikos E., Voultsos P., Vlachaki A., & Pavlidis P. (2017).  Sexual homicide: Brief review of the literature and case report involving rape, genital mutilation and human arson.. J Forensic Leg Med. 46, 1-10.
Karakasi, M. V., Tologkos S., Papadatou V., Raikos N., Lambropoulou M., & Pavlidis P. (2019).  Conium maculatum intoxication: Literature review and case report on hemlock poisoning.. Forensic Sci Rev. 31(1), 23-36.
Karaiskos, T., Tomos P., Asouhidou I., Nikiteas N., Kontakiotis T., & Papalois A. (2012).  Oxidative and pre-inflammatory stress in wedge resection of pulmonary parenchyma using the radiofrequency ablation technique in a swine model.. J Cardiothorac Surg. 7, 7.
Karaiskos, P., Moutsatsos A., Pappas E., Georgiou E., Roussakis A., Torrens M., et al. (2014).  A simple and efficient methodology to improve geometric accuracy in gamma knife radiation surgery: implementation in multiple brain metastases.. Int J Radiat Oncol Biol Phys. 90(5), 1234-41.
Karagkouni, D., Paraskevopoulou M. D., Chatzopoulos S., Vlachos I. S., Tastsoglou S., Kanellos I., et al. (2018).  DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions.. Nucleic Acids Res. 46(D1), D239-D245.
Karagkiozaki, V. C., Logothetidis S. D., Kassavetis S. N., & Giannoglou G. D. (2010).  Nanomedicine for the reduction of the thrombogenicity of stent coatings.. Int J Nanomedicine. 5, 239-48.
Karagiozoglou-Lampoudi, T., Zellos A., Vlahavas G., Kafritsa Y., Roma E., Papadopoulou A., et al. (2013).  Screening for coeliac disease in preschool Greek children: the feasibility study of a community-based project.. Acta Paediatr. 102(7), 749-54.
Karagiozoglou-Lampoudi, T., Trachana M., Agakidis C., Pratsidou-Gertsi P., Taparkou A., Lampoudi S., et al. (2011).  Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity.. Metabolism. 60(10), 1359-62.
Karagiozoglou-Lampoudi, T., Daskalou E., Vargiami E., & Zafeiriou D. (2012).  Identification of feeding risk factors for impaired nutrition status in paediatric patients with cerebral palsy.. Acta Paediatr. 101(6), 649-54.
Karagiannis, A., Pyrpasopoulou A., Tziomalos K., Florentin M., & Athyros V. (2006).  Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors.. QJM. 99(3), 197-8.
Karagiannis, T., Paschos P., Paletas K., Matthews D. R., & Tsapas A. (2012).  Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.. BMJ. 344, e1369.
Karagiannis, A., Mathiopoulou L., Tziomalos K., Kontotasios K., Skaperdas A., Florentin M., et al. (2006).  Dry cough as first manifestation of giant-cell arteritis.. J Am Geriatr Soc. 54(12), 1957-8.
Karagiannis, A. D., Liu M., Toth P. P., Zhao S., Agrawal D. K., Libby P., et al. (2018).  Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation.. Curr Atheroscler Rep. 20(4), 20.
Karagiannis, A., Tziomalos K., & Athyros V. G. (2007).  Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?. Ann Allergy Asthma Immunol. 98(5), 502.
Karagiannis, A., Balaska K., Tziomalos K., Gerasimidis T., Karamanos D., Papayeoryiou A., et al. (2004).  Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease.. Vasc Med. 9(3), 189-92.
Karagiannis, T., Liakos A., Branda M. E., Athanasiadou E., Mainou M., Boura P., et al. (2016).  Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial. BMJ Open. 6(11), e012185.
Karagiannis, T., Avgerinos I., Liakos A., Del Prato S., Matthews D. R., Tsapas A., et al. (2022).  Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.. Diabetologia. 65(8), 1251-1261.
Karagiannis, T., & Bekiari E. (2016).  Most add-on therapies to metformin have similar effects on HbA1c.. Evid Based Med. 21(6), 223.
Karagiannis, A. K. A., Dimitropoulou F., Papatheodorou A., Lyra S., Seretis A., & Vryonidou A. (2016).  Pituitary abscess: a case report and review of the literature.. Endocrinol Diabetes Metab Case Rep. 2016, 160014.
Karagiannis, A., Tziomalos K., Dona K., Pyrpasopoulou A., Kartali N., Athyros V., et al. (2005).  Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient.. QJM. 98(12), 913-5.
Karagiannis, A., Athyros V. G., Papageorgiou A., Tziomalos K., & Elisaf M. (2006).  Should atenolol still be recommended as first-line therapy for primary hypertension?. Hellenic J Cardiol. 47(5), 298-307.
Karagiannis, A., Douma S., Voyiatzis K., Petidis K., Athyros V., Vizantiadis A., et al. (1995).  Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term results.. Hypertens Res. 18(1), 27-31.
Karagiannis, A., Tziomalos K., Anagnostis P., Gossios T. D., Florentin M., Athyros V. G., et al. (2010).  The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.. Curr Vasc Pharmacol. 8(6), 792-803.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Kakafika A. I., & Athyros V. G. (2008).  Has the time come for a new definition of microalbuminuria?. Curr Vasc Pharmacol. 6(2), 81-3.
Karagiannis, T., Bekiari E., & Tsapas A. (2023).  Socioeconomic aspects of incretin-based therapy.. Diabetologia. 66(10), 1859-1868.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές